INDOCO REMEDIES LTD. Financial Ratios
INDOCO · Healthcare · Current price ₹243.3
P/E ratio
712.7x
P/B ratio
2.4x
ROE
-9.4%
ROCE
1.0%
Debt / Equity
0.69
Dividend yield
0.1%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 712.7x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.4x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -9.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 1.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.69 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with INDOCO REMEDIES LTD.'s latest numbers.
INDOCO REMEDIES LTD. profitability
INDOCO REMEDIES LTD. generates a return on equity of -9.4% and a return on capital employed of 1.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.69 and a P/E of 712.7x, INDOCO REMEDIES LTD. is moderately leveraged. Our overall business-quality score for the company is 2.4 / 10.
Understand the ratios
More on INDOCO REMEDIES LTD.
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.